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Abstract
Background: Trichomonas vaginalis is a flagellated protozoan causing trichomoniasis, a sexually transmitted human
infection, with around 276.4 million new cases estimated by World Health Organization. Culture is the gold
standard method for the diagnosis of T. vaginalis infection. Recently, immunochromatographic assays as well as PCR
assays for the detection of T. vaginalis antigen or DNA, respectively, have been also available. Although the
well-known genome sequence of T. vaginalis has made possible the application of proteomic studies, few data are
available about the overall proteomic expression profiling of T. vaginalis. The aim of this study was to investigate
the potential application of MALDI-TOF MS as a new tool for the identification of T. vaginalis.
Methods: Twenty-one isolates were analysed by MALDI-TOF MS after the creation of a Main Spectrum Profile (MSP)
from a T. vaginalis reference strain (G3) and its subsequent supplementation in the Bruker Daltonics database, not
including any profile of protozoa. This was achieved after the development of a new identification method created
by modifying the range setting (6–10 kDa) for the MALDI-TOF MS analysis in order to exclude the overlapping of
peaks derived from the culture media used in this study.
Results: Two MSP reference spectra were created in 2 different range: 3–15 kDa (standard range setting) and
6–10 kDa (new range setting). Both MSP spectra were deposited in the MALDI BioTyper database for further
identification of additional T. vaginalis strains. All the 21 strains analysed in this study were correctly identified by
using the new identification method.
Conclusions: In this study it was demonstrated that changes in the MALDI-TOF MS standard parameters usually
used to identify bacteria and fungi allowed the identification of the protozoan T. vaginalis. This study shows the
usefulness of MALDI-TOF MS in the reliable identification of microorganism grown on complex liquid media such
as the protozoan T. vaginalis, on the basis of the proteic profile and not on the basis of single markers, by using a
“new range setting” different from that developed for bacteria and fungi.
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Background
Trichomonas vaginalis is a flagellated protozoan of the
urogenital tract belonging to the order Trichomonadida
[1] and it is the aetiologic agent of trichomoniasis [2],
the most common non-viral sexually transmitted infec-
tion (STI) worldwide [3]. As reported by the World
Health Organization (WHO), the 2008 global estimate
of the number of new cases for trichomoniasis is 11.2 %
higher than the estimate for 2005 (276.4 million versus
248.5 million) [4].
The main pathological manifestations of T. vaginalis
infection in women are abdominal pain, itching, and the
presence of a foul-smelling discharge with abundant
leukocytes, while in men the infection is mostly asymp-
tomatic, although it can sometimes lead to urethritis,
prostatitis, and epididymitis [2, 5].
The visualisation of the morphostructural characteris-
tics of the motile parasites by microscopic examination
of wet mounts (sensitivity 51–65 %) from vaginal and
urethral secretions is the most practical and rapid but
relatively insensitive method used for the diagnosis of
trichomoniasis [6]. Direct immunofluorescent antibody
staining is more sensitive than wet mounts but technic-
ally complex. Culture (sensitivity 75–96 %, specificity
100 %) of the parasite is the gold standard for the diag-
nosis of trichomoniasis, but it is not widely used and the
results are not available for 3 to 7 days [6]. Recently,
immunochromatographic assays (sensitivity 82–95 %,
specificity 97–100 %) for the detection of specific anti-
gens of T. vaginalis, as well as PCR assays (sensitivity
and specificity 95–100 %) for the detection of T. vaginalis
DNA have been also available [2, 6–8].
The T. vaginalis genome sequencing was completed in
2007 [9, 10]. The parasite genome is organized in six
chromosomes and the number of protein-coding genes
is estimated at about 60,000 [10]. The availability of T.
vaginalis genomic sequences makes possible and prac-
tical the application of proteomic methods to the study
of global patterns of gene expression. Several laborator-
ies have contributed to understanding the protein
expression of T. vaginalis [10]. However, these studies
are focused on specific proteins, and little is known
about the overall profile of this parasite [10].
Matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOF MS) is widely
employed to determine the mass of peptides and pro-
teins [11]. Key aspect of whole-cell MALDI-TOF MS is
the rapid generation and comparison of mass spectra.
The peaks of these mass spectra represent abundant
cellular proteins [12]. The quality of these spectra was
improved particularly by the optimization of sample
preparation procedure and matrix composition [13].
This technology has been adopted for the rapid identifi-
cation of bacterial and fungal isolates in the clinical
microbiology laboratory where it has replaced traditional
identification methods [11, 14–17].
In human parasitology, MALDI-TOF MS has had
limited application, such as the detection of malarial
hemozoin in blood [18], parasites identification [19–21]
or detection of their biomarkers by MALDI-TOF MS
(eg. [22–25]). Recently, MALDI-TOF MS was applied
for the first time to the differentiation of E. histolytica
and E. dispar strains isolated from clinical samples [26].
The aim of this study was the development of a
MALDI-TOF MS identification method for microorgan-
isms different from bacteria and fungi that grow on
complex liquid complex media. In this study for the first
time the potential application of MALDI-TOF MS as a
new tool for the reliable identification of T. vaginalis
was investigated. This was done by the implementation
of the commercial database (version 3.1.66) of the
MALDI-TOF mass spectrometer currently used in our
laboratory, with the spectrum of a T. vaginalis reference
strain after creation of a specific proteic reference
profile.
Methods
Strains, samples and culture procedures
Trophozoites of T. vaginalis strain G3 [27] (kindly pro-
vided by Prof. Pier Luigi Fiori, Department of Biomedical
Sciences, University of Sassari, Italy) were axenically cul-
tivated at 37 °C for at least 3 days in “Trypticase-yeast
extract maltose” (TYM) medium pH 6.6, supplemented
with fetal bovine serum (final concentration 10 %) inac-
tivated at 56 °C for 30 min [28].
Twenty-one T. vaginalis strains belonging to our
collection (Tv1-Tv21) were isolated from clinical samples
(19 vaginal swabs, 1 urine, and 1 urethral swab) during a
10-year period (from 2005 to 2014). For the MALDI-
TOF MS analysis the 21 strains were cultivated in
“Trichomonas medium N.2” (Oxoid, Perth, UK) at 37 °C
for at least 3 days and in any case until the elimin-
ation of bacteria and yeasts derived from the micro-
biota of the host. All the 22 cultivated strains (the G3
reference strain and 21 clinical strains) were analysed
by MALDI-TOF MS when the trophozoites concen-
tration was 106/ml.
MALDI-TOF MS was also performed directly on a
urine sample (N. 20), belonging to a patient with tricho-
moniasis, sent to our laboratory at room temperature
and stored at 4 °C for 5 h before the analysis.
Subsequently, a T. vaginalis strain (Tv20) was isolated
from this sample. Briefly, a 15 ml aliquot of the sample
N. 20 was centrifuged and the obtained pellet was re-
suspended in 1.5 ml of sterile Trichomonas medium N.2.
The strain Tv20 was isolated by adding a 2 ml aliquot of
the urine sample to 2 ml of Trichomonas medium N.2
and cultivated as described above.
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Three experimentally seeded samples with the T. vagi-
nalis strain (Tv15) were prepared as follows: 1 vaginal
swab, 1 urethral swab and 1 urine sample collected in
Uriswab™ (Urine Collection Transport & Preservation
System, COPAN, Italy), subjected to the diagnosis of in-
fections by microbes other than T. vaginalis, all nega-
tives for T. vaginalis and other pathogenic microbes,
were moistened in a volume of 500 μl of Tv15 at a con-
centration of 106 trophozoites/ml and subsequently put
in 500 μl of double-distilled sterile water to release the
absorbed trophozoites. The suspensions obtained (< 106
trophozoites/ml) were subjected to MALDI-TOF MS
analysis as described below.
The samples analysed in this study were sent to the
University Hospital of Parma for routine diagnostic pur-
poses, and the laboratory diagnosis results were reported
in the medical records of the patients as answer to a
clinical suspicion; ethical approval at the University Hos-
pital of Parma is required only in cases in which the
clinical samples are to be used for applications other
than diagnosis. Thus, for this study the ethics committee
approval was unnecessary in accordance with local legis-
lation and guidelines.
Sample preparation for MALDI-TOF MS analysis
Aliquots of 1.5 ml obtained from T. vaginalis reference
strain G3, 21 isolates, and the urine sample N.20, and al-
iquots of 0.5 ml obtained from the 3 experimentally
seeded samples were subjected to MALDI-TOF MS ana-
lysis after protein extraction in ethanol/formic acid, as
previously described [15–17] with some modifications.
Briefly, each aliquot was centrifuged at 1800 × g for
10 min and the supernatant was discarded. The pellet
obtained was subjected to two subsequent washing steps
in PBS in 1 ml and in 0.2 ml respectively, both followed
by centrifugation at 2500 × g for 5 min. The obtained
pellet was suspended in distilled water and in absolute
ethanol in a 1:3 ratio. The suspension was centrifuged at
13,000 × g for 10 min and the supernatant was dis-
carded. After 40 min of air-drying to evaporate the etha-
nol residue, 30 μl of 70 % formic acid and 30 μl of
acetonitrile were added and the suspension was vortexed
for 1 min and centrifuged at 13,000 × g for 2 min. Then,
1 μl of the supernatant was transferred to a polished
steel MSP-96 target plate (Bruker Daltonics, Germany)
and allowed to dry at room temperature before being
overlaid with 1 μl of a satured α-cyano-4-hydroxy-
cinnamic acid (HCCA) matrix solution (Bruker Daltonics).
In each session, TYM axenic medium and/or Tricho-
monas medium N.2, subjected to the same protein ex-
traction procedure, were used as controls accordingly to
the strains tested. In each experiment, the “Bacterial
Test Standard” (Bruker Daltonics) for calibration was
used according to the manufacturer’s instructions.
Spectra acquisition by MALDI-TOF MS
Proteic extracts were analysed by MicroFlex LT mass
spectrometer (Bruker Daltonics, supplied by Becton
Dickinson, Italy); spectra were acquired in positive linear
mode, laser frequency 60 Hz, ion source voltage 20 kV,
mass range 2–20 kDa, in manual mode with overall 400
laser-shot by 100 shot steps. Each shot step was made in
different points of the well with a laser intensity of 30 %
for each single shot step.
For all the reference and clinical strains tested at least
2 independent experiments from 2 independent cultures
on 2 different days were run (inter-assay reproducibility)
and 8 replicates/run (intra-assay reproducibility) were
analysed in order to ensure the reproducibility of the re-
sults obtained.
In order to minimize the variability associated with
technical or biological parameters, the experiments were
performed under controlled cultivation and sample
preparation conditions or technical configurations, as-
suring a high repeatability and reproducibility among
experiments.
Database creation and identification
MALDI BioTyper database was implemented with the
Main Spectrum Profile (MSP) of the T. vaginalis refer-
ence strain G3 created as described below. The raw
spectra acquired by MALDI-TOF MS were analysed by
FlexAnalysis software to carry out “Smoothing” and
“Baseline” and to delete spectra with an overall intensity
<104 arbitrary units and spectra fully different from the
others. Ten spectra of T. vaginalis strain G3 were
uploaded in MALDI BioTyper software (Version 3.1,
Bruker Daltonics).
Two different MSP-Spectra were created by the auto-
mated function of BioTyper software (BioTyper MSP
Creation Standard Methods) in two range settings re-
spectively: 6–10 kDa (new parameter used in this study)
and 3–15 kDa (default parameter). The new range set-
ting (6–10 kDa) was established after analysis by Flex
Analysis software of the spectra obtained for T. vaginalis
G3, TYM axenic medium, and Trichomonas medium
N.2 in 3 independent experiments.
All the spectra obtained for the 21 isolated strains
were subjected to identification by Biotyper software
by both the new and the standard range setting. At
the time of the analysis, the database library included
5675 spectra and T. vaginalis G3 spectrum. Parasitic
spectra were not available in the commercially
database library used. Results were expressed as iden-
tification scores varying from 0 to 3. According to
the manufacturer’s instructions validated for bacteria
and fungi and to what reported also for other para-
sites [20], a score value ≥2 indicates a species level
identification; a score value 1.7-2 indicates a genus
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level identification; and a score value <1.7 indicates
an unreliable identification.
Detection limit of MALDI-TOF MS
In order to evaluate the detection limit of the analysis by
MALDI-TOF MS, serial ten-fold dilutions (from 106 to
10 trophozoites/ml) of Tv15 trophozoites were mixed
with an equal volume (1.5 ml) of sterile PBS without
Ca2+ and Mg2+. Subsequently, 1 ml of each dilution was
centrifuged at 1800 × g for 10 min and the pellet obtained
was subjected to the same protein extraction procedure
described above.
Results
The spectra obtained with all the replicates of T. vagina-
lis reference strain G3, acquired in two independent ex-
periments, matched none of the existing spectra profiles
in the database (score value <1.2). The spectra of T.
vaginalis strain G3 and the spectra of the culture
medium (TYM axenic medium or of Trichomonas
medium N. 2) acquired by MALDI-TOF MS and
analysed by FlexAnalysis software in the range 2–6 kDa
showed common peaks. The same spectra analysed in
the range 6–10 kDa did not show common peaks. The
spectra of T. vaginalis strain G3 analysed in the range
10–20 kDa did not show any peaks (Fig. 1).
Two MSP reference spectra were created in 2 different
range: 3–15 kDa (standard range setting) and 6–10 kDa
(new range setting).
The 2 MSP reference spectra of T. vaginalis obtained
in the new range setting (6–10 kDa) and in the standard
range setting (3–15 kDa), respectively, were both
deposited in the MALDI BioTyper database for further
identification of additional T. vaginalis strains. These
reference profiles proved to be reproducible in a second
independent experiment, performed after the database
implementation, when a correct identification was found
for all the replicates of the strain (score of the best
match >2.4). In the range setting 6–10 kDa, all the 21
isolates were identified as T. vaginalis, 12 (Tv1-Tv8,
Tv17-Tv20) with a score value ≥ 2.0 for each of the repli-
cates and 9 (Tv9-Tv16, and Tv21) with a score value
Fig. 1 Proteic profiles of the T. vaginalis reference strain G3 and of the culture media. Spectra obtained for T. vaginalis reference strain G3 and for
the media “Trypticase-yeast extract maltose (TYM)” and “Trichomonas medium N. 2”, respectively, by MALDI-TOF MS analysis. The box with dashed
line highlights the 3 spectra in the molecular range 3–15 kDa; the box with continuous line highlights the 3 spectra in the molecular
range 6–10 kDa
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comprised between 1.7 and 2.0. In the standard range
setting (3–15 kDa), 6 of the 21 strains (Tv1-Tv6) were
identified as T. vaginalis with a score value comprised
between 1.7 and 2.0 and the remaining 15 isolates (Tv7-
Tv21) were not identified (Table 1). The spectra obtained
for the 21 isolates in the range setting 6–10 kDa were
shown in Fig. 2.
No identification was obtained when the MALDI-TOF
MS was applied both on the pellet obtained from the
urine sample N. 20 (score value < 1.4) and on the 3 sam-
ples experimentally seeded (1 vaginal swab, 1 urethral
swab and 1 urine sample collected in Uriswab™) with the
strain Tv15 (score value <1.7).
In this study, MALDI-TOF MS for the identification
of T. vaginalis showed a detection limit of 105 trophozo-
ites/ml.
Discussion
MALDI-TOF MS has revolutionised the diagnostic
work-flow in bacteriology and mycology replacing trad-
itional identification methods [11]. Thus, now it repre-
sents one of the most used techniques for the
identification of pathogenic microorganisms [13, 19, 20].
However, in parasitology, MALDI-TOF MS had limited
applications such as general parasitic proteome studies
and the characterisation of specific biomarkers. As a
Table 1 Compared results by MALDI-TOF MS analysis using the new and the standard identification methods
MALDI-TOF MS analysis
New identification method Standard identification method
Range setting (6–10 kDa) Range setting (3–15 kDa)
Clinical isolates Identification Score Identification Score
Tv1a T. vaginalis G3 2.0 T. vaginalis G3 1.9
Tv2a T. vaginalis G3 2.2 T. vaginalis G3 1.9
Tv3a T. vaginalis G3 2.1 T. vaginalis G3 1.7
Tv4a T. vaginalis G3 2.1 T. vaginalis G3 1.7
Tv5a T. vaginalis G3 2.3 T. vaginalis G3 1.7
Tv6a T. vaginalis G3 2.2 T. vaginalis G3 1.7
Tv7a T. vaginalis G3 2.2 No identification NA
Tv8a T. vaginalis G3 2.1 No identification NA
Tv9a T. vaginalis G3 1.7 No identification NA
Tv10a T. vaginalis G3 1.7 No identification NA
Tv11a T. vaginalis G3 1.7 No identification NA
Tv12a T. vaginalis G3 1.9 No identification NA
Tv13a T. vaginalis G3 1.8 No identification NA
Tv14a T. vaginalis G3 1.7 No identification NA
Tv15a T. vaginalis G3 1.7 No identification NA
Tv16a T. vaginalis G3 1.7 No identification NA
Tv17a T. vaginalis G3 2.0 No identification NA
Tv18a T. vaginalis G3 2.0 No identification NA
Tv19a T. vaginalis G3 2.0 No identification NA
Tv20b T. vaginalis G3 2.0 No identification NA
Tv21c T. vaginalis G3 1.7 No identification NA
Samples
Urine N. 20 No identification NA No identification NA
Vaginal swabd No identification NA No identification NA
Urethral swabd No identification NA No identification NA
Urine swabd No identification NA No identification NA
Tv Trichomonas vaginalis, NA not applicable
aisolated from vaginal swab
bisolated from urine
cisolated from urethral swab
dexperimentally seeded sample with Tv15
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matter of fact, its diagnostic use in parasitology has
remained limited [20], only being applied to Leishmania
sp. identification [19, 21], to the discrimination of micro-
sporidian isolates grown on cell cultures [24], and to the
typing of Blastocystis sp. from axenic cultures [20].
Recently, our group had demonstrated the usefulness of
MALDI-TOF MS for the differentiation of Entamoeba
histolytica and E. dispar [26].
MALDI-TOF MS was previously used for the assess-
ment of the first reference proteome map of T. vaginalis
[10] and, to our knowledge, the present study is the first
reporting the application of MALDI-TOF MS to the
identification of T. vaginalis.
In this study MALDI-TOF MS was applied to identify
21 T. vaginalis isolates after the creation of a specific
proteic reference profile by using the T. vaginalis refer-
ence strain G3.
The proteic profile of the T. vaginalis reference strain
G3 was found to be original, matching none of the exist-
ing profile in the Bruker Daltonics database even if some
peaks overlapped those present in the spectra of the cul-
ture media used in this study. The new identification
method applied in this study, based on the creation of a
MSP-spectrum in the 6–10 kDa mass range to identify
unknown spectra, allowed to overcome these overlap-
ping. Although, as already reported, metabolites, pig-
ment and the other materials present in a culture
medium may interfere with the crystallisation process
and lead to a lower score values [20], in the selected
mass-range (6–10 kDa) the components of the both
media used did not affect the identification of T. vagina-
lis. In fact, this new method has proved to be necessary
because in 15 cases allowed the correct identification of
the protozoan not otherwise achievable by the standard
mode, and in 6 cases it allowed the identification with a
better score as compared to the standard mode. The
correct identification of T. vaginalis isolates by means of
the new method has also been achieved in those cases
where bacteria and yeasts resulting from the microbiota
of the host (i.e., in the case of vaginal swabs N. 10) were
still present. In the mass range 3–6 kDa, the MSP of G3
strain presented peaks of the TYM medium, not de-
tected both in the Trichomonas medium N.2 and in the
clinical isolates grown in this medium, which were con-
sidered relevant by the algorithm of the identification
using standard parameter setting (3–15 kDa); the better
score obtained with the new range setting could be due
to the exclusion of the mass range 3–6 kDa including
these peaks.
The reported low sensitivity of MALDI-TOF MS tech-
nology [12] is confirmed also in this study where a de-
tection limit of 105 trophozoites/ml was observed. This
could not allow the identification of T. vaginalis directly
in clinical samples, as suggested by the preliminary
Fig. 2 Proteic profiles of the 21 T. vaginalis isolates analysed in this
study. Spectra obtained with the 21 T. vaginalis isolates by MALDI-
TOF MS analysis in the molecular range 6–10 kDa
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results obtained for the 3 experimentally seeded samples
analysed in this study and for the urine sample N. 20
analysed after only 5 h from its arrival in the laboratory
and immediately stored at 4 °C. Moreover, the limited
number of reference strains implemented in the data-
base (one strain) could have affected, in these cases, the
reliability of the identification by MALDI-TOF MS.
Thus, this technology has a limitation for its potential
application to the diagnostic work-flow of trichomonia-
sis as it can be performed only in samples presenting a
very high concentration of the parasite, or after its cul-
ture. Anyway, unlike the culture, MALDI-TOF MS does
not require the viability of the parasite. Moreover, com-
pared to rapid antigen tests, MALDI-TOF MS is not
limited in the application to vaginal secretion, and com-
pared to nucleic acid amplification tests, not widely per-
formed in parasitology laboratories, is less cumbersome
and expensive. In any case, the preliminary results ob-
tained in this study could be a starting point for further
evolutions of the developed system. The development of
an efficient identification method is required to identify
protozoa grown on complex liquid media for which
interfering substances cannot be completely discarded
by the pre-processing protocol before the identification
step.
Conclusions
The importance of this preliminary study lies essentially
in the development of a new identification method by
MALDI-TOF MS: it has made possible to identify, on
the basis of the proteic profile and not on the basis of
single markers, a microorganism such as the protozoan
T. vaginalis which was grown on complex media that
could present peaks overlapping those of the micro-
organism itself in the molecular weight range used for
identification purposes by MALDI-TOF MS. In fact, the
executive protocol commonly used in diagnostic practice
in a range 3–15 kDa was developed for bacteria and
fungi which generally require solid growth media not
giving interferences in this mass range. Further experi-
ments must be conducted to validate the clinical diag-
nostic performance of T. vaginalis MALDI-TOF MS
assay that could be a potential tool for the application
also in the diagnostic work-flow in trichomoniasis, as
already proposed in recent studies (i.e., [19, 20, 26]) for
other parasites.
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